Anti-inflammatory drugs

The European Commission ( EC ) has granted marketing authorisation for Olumiant ( Baricitinib ) 4 mg and 2 mg...


Results of the landmark PRECISION ( Prospective Randomized Evaluation of Celecoxib Integrated Safety vs Ibuprofen Or Naproxen ) trial demonstrated...


The FDA ( Food and Drug Administration ) has strengthened the existing warning about the risk of acute kidney injury...


The U.S. Food and Drug Administration ( FDA ) has approved once-daily Yosprala, the only prescription fixed-dose combination of Aspirin,...


The FDA ( Food and Drug Administration ) is strengthening an existing label warning that non-Aspirin nonsteroidal anti-inflammatory drugs (...


Enhanced cardiovascular risk in ankylosing spondylitis provides a strong rationale for early therapeutical intervention. In view of the proven benefit...


The Committee for Medicinal Products for Human Use ( CHMP ) has recommended the approval of Cosentyx ( Secukinumab )...


Ibuprofen is a non-steroidal anti-inflammatory drug ( NSAID ) used to treat pain, reduce fever, and relieve inflammation. A safety review...


Nonsteroidal anti-inflammatory drugs ( NSAIDs ) have been assigned a promising role in the chemoprevention of various malignancies. However, epidemiological...


The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases are published in European Heart Journal. Previous ESC...


It is known that many medical adverse events can be caused by nonsteroidal anti-inflammatory drugs ( NSAIDs ); however, epidemiologic...


Since the publication of the European League Against Rheumatism ( EULAR ) recommendations for the pharmacological treatment of psoriatic arthritis...


Non-steroidal anti-inflammatory drugs ( NSAIDs ) have received increasing attention as potential chemopreventive agents of skin cancer but evidence is...


This is an update of a Cochrane review first published in 2006. Gout is one of the most common rheumatic...


Increased oxidative stress and inflammation has a role in the pathogenesis of chronic obstructive pulmonary disease ( COPD ). Drugs...


Persistent pain is highly prevalent, costly, and frequently disabling in later life. Researchers have described barriers to the management of...


A study has evaluated the long-term response and safety of interleukin-1 receptor antagonist, Anakinra ( Kineret ) in recurrent pericarditis. Fifteen...


Conclusive data about cardiovascular toxicity of nonsteroidal anti-inflammatory drugs ( NSAIDs ) are sparse. It has been hypothesized that regular...


Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells...


The FDA ( Food and Drug Administration ) has approved the first generic versions of Celebrex ( Celecoxib ) capsules,...